StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.57−0.27 (-14.40%)

Close on Nov 16, 2026Market cap $2.50MP/E –Yield –

Silo Pharma total assets

Total assets on the balance sheet at the end of each period.

Silo Pharma's total assets was $5.95M at Jun 30, 2026. For fiscal 2025 it was $7.61M, up 2.6% from the year before. Over ten years it grew 177.7% a year on average. The highest annual figure on record is $11.64M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.61M+2.6%
FY2024Dec 31, 2024$7.41M-4.3%
FY2023Dec 31, 2023$7.75M-33.5%
FY2022Dec 31, 2022$11.64M+11.0%
FY2021Dec 31, 2021$10.49M+635.3%
FY2020Dec 31, 2020$1.43M+188.9%
FY2019Dec 31, 2019$493.85K-42.3%
FY2018Dec 31, 2018$855.42K-47.9%
FY2017Dec 31, 2017$1.64M-25.6%
FY2013Dec 31, 2013$2.21M+791077.1%
FY2012Dec 31, 2012$279-84.1%
FY2011Dec 31, 2011$1.75K-96.3%
FY2010Dec 31, 2010$47.48K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.95M-10.5%
Q1 FY2026Mar 31, 2026$7.02M+19.0%
Q4 FY2025Dec 31, 2025$7.61M+2.6%
Q3 FY2025Sep 30, 2025$6.38M-25.5%
Q2 FY2025Jun 30, 2025$6.65M-17.2%
Q1 FY2025Mar 31, 2025$5.90M-23.8%
Q4 FY2024Dec 31, 2024$7.41M-17.5%
Q3 FY2024Sep 30, 2024$8.57M-16.4%
Q2 FY2024Jun 30, 2024$8.04M-31.0%
Q4 FY2023Dec 31, 2023$7.75M-40.6%
Q3 FY2023Sep 30, 2023$8.99M-0.6%
Q1 FY2023Jun 30, 2023$10.25M+5.5%
Q4 FY2022Dec 31, 2022$11.64M+11.0%
Q3 FY2022Sep 30, 2022$13.05M+14.6%
Q2 FY2022Jun 30, 2022$9.04M+80.8%
Q1 FY2022Mar 31, 2022$9.72M+76.6%
Q4 FY2021Dec 31, 2021$10.49M+635.3%
Q3 FY2021Sep 30, 2021$11.39M+416.8%
Q2 FY2021Jun 30, 2021$5.00M+79.0%
Q1 FY2021Mar 31, 2021$5.50M+1262.3%
Q4 FY2020Dec 31, 2020$1.43M+188.9%
Q3 FY2020Sep 30, 2020$2.20M+470.2%
Q2 FY2020Jun 30, 2020$2.80M+422.1%
Q1 FY2020Mar 31, 2020$403.82K-46.2%
Q4 FY2019Dec 31, 2019$493.85K-42.3%
Q3 FY2019Sep 30, 2019$386.53K-73.1%
Q2 FY2019Jun 30, 2019$535.54K-67.4%
Q1 FY2019Mar 31, 2019$750.85K-66.0%
Q4 FY2018Dec 31, 2018$855.42K+132.0%
Q3 FY2018Sep 30, 2018$1.44M+14116.0%
Q4 FY2017Dec 31, 2017$1.64M+588210.0%
Q4 FY2013Dec 31, 2013$2.21M+791077.1%
Q2 FY2013Jun 30, 2013$368.68K–
Q1 FY2013Mar 31, 2013$10.10K–
Q4 FY2012Dec 31, 2012$279–
Q3 FY2012Sep 30, 2012$279–

More Silo Pharma figures

See a number that looks wrong?